Simplifying Global Compliance
Drugmakers Argue Carve-Out Case Before Supreme Court
Washington Drug Letter
U.S. Supreme Court Justices sharply questioned drug industry attorneys Dec. 5 as the court prepares to define the FDA’s authority in accepting and challenging brand drugmakers’ patent use codes for products.
To View This Article:
Buy This Article Now
Copyright ©2018. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing